72 related articles for article (PubMed ID: 35488235)
1. Preoperative risk factors of lymph node metastasis in clinical N0 lung adenocarcinoma of 3 cm or less in diameter.
Fang C; Xiang Y; Han W
BMC Surg; 2022 Apr; 22(1):153. PubMed ID: 35488235
[TBL] [Abstract][Full Text] [Related]
2. Lymph node metastasis and its risk factors in T1 lung adenocarcinoma.
Zhang W; Mu G; Huang J; Bian C; Wang H; Gu Y; Xia Y; Chen L; Yuan M; Wang J
Thorac Cancer; 2023 Oct; 14(30):2993-3000. PubMed ID: 37667435
[TBL] [Abstract][Full Text] [Related]
3. Is tumor diameter a risk factor for occult N1 metastasis in patients with peripheral non-small cell lung cancer which is smaller than 3 cm?
Sayan M; Celik A; Kankoc A; Akarsu I; Aslan MT; Kurtoglu A; Ahmedova G; Tastepe AI
Updates Surg; 2023 Dec; 75(8):2335-2342. PubMed ID: 37382803
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for lymph node metastasis and surgical scope in patients with cN0 non-small cell lung cancer: a single-center study in China.
Jianlong B; Pinyi Z; Xiaohong W; Su Z; Sainan P; Jinfeng N; Shidong X
J Cardiothorac Surg; 2021 Oct; 16(1):304. PubMed ID: 34663403
[TBL] [Abstract][Full Text] [Related]
5. Extent of Lymph Node Dissection in Patients with Small-Sized Peripheral Non-Small Cell Lung Cancer during Intentional Segmentectomy.
Maniwa T; Ohue M; Shintani Y; Okami J
Ann Thorac Cardiovasc Surg; 2023 Dec; 29(6):271-278. PubMed ID: 37100608
[TBL] [Abstract][Full Text] [Related]
6. Selective Mediastinal Lymph Node Dissection Strategy for Clinical T1N0 Invasive Lung Cancer: A Prospective, Multicenter, Clinical Trial.
Zhang Y; Deng C; Zheng Q; Qian B; Ma J; Zhang C; Jin Y; Shen X; Zang Y; Guo Y; Fu F; Li H; Zheng S; Wu H; Huang Q; Wang S; Liu Q; Ye T; Sun Y; Zhang Y; Xiang J; Hu H; Li Y; Chen H
J Thorac Oncol; 2023 Jul; 18(7):931-939. PubMed ID: 36841542
[TBL] [Abstract][Full Text] [Related]
7. A simple nomogram for predicting occult lymph node metastasis of non-small cell lung cancer from preoperative computed tomography findings, including the volume-doubling time.
Karita R; Suzuki H; Onozato Y; Kaiho T; Inage T; Ito T; Tanaka K; Sakairi Y; Yoshino I
Surg Today; 2024 Jan; 54(1):31-40. PubMed ID: 37129682
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric evaluation of mediastinal lymph node metastases in clinical T0-T1c stage non-small-cell lung cancers.
Wang S; Bao X; Yang F; Shi H
Eur J Cardiothorac Surg; 2024 Mar; 65(3):. PubMed ID: 38429956
[TBL] [Abstract][Full Text] [Related]
9. Growth characteristics of early-stage (IA) lung adenocarcinoma and its value in predicting lymph node metastasis.
Liu M; Mu J; Song F; Liu X; Jing W; Lv F
Cancer Imaging; 2023 Dec; 23(1):115. PubMed ID: 38041175
[TBL] [Abstract][Full Text] [Related]
10. Predictability and Utility of Contrast-Enhanced CT on Occult Lymph Node Metastasis for Patients with Clinical Stage IA-IIA Lung Adenocarcinoma: A Double-Center Study.
Zhao F; Zhao Y; Zhang Y; Sun H; Ye Z; Zhou G
Acad Radiol; 2023 Dec; 30(12):2870-2879. PubMed ID: 37003873
[TBL] [Abstract][Full Text] [Related]
11. Association between number of dissected lymph nodes and survival in patients undergoing resection for clinical stage IA pure solid lung adenocarcinoma: a retrospective analysis.
Rong Y; Liu J; Han N; Shi Z; Jiang T; Zhang N; Xu X; Yin J; Du H
BMC Pulm Med; 2023 Oct; 23(1):401. PubMed ID: 37865730
[TBL] [Abstract][Full Text] [Related]
12. A component of high-grade fetal lung adenocarcinoma diagnosed as the cause of lymph node metastasis.
Ishii D; Aoyama S; Arai W; Hasegawa M; Tanaka A; Sakuraba M
Thorac Cancer; 2024 May; 15(13):1112-1116. PubMed ID: 38528648
[TBL] [Abstract][Full Text] [Related]
13. Importance of Lymph Node Evaluation in ≤2-cm Pure-Solid Non-Small Cell Lung Cancer.
Choi S; Yoon DW; Shin S; Kim HK; Choi YS; Kim J; Shim YM; Cho JH
Ann Thorac Surg; 2024 Mar; 117(3):586-593. PubMed ID: 36608755
[TBL] [Abstract][Full Text] [Related]
14. An accurate prediction of negative lymph node metastasis with consideration of glucose metabolism in early-stage non-small cell lung cancer.
Onodera K; Aokage K; Wakabayashi M; Ikeno T; Morita T; Ohashi S; Miyoshi T; Tane K; Samejima J; Tsuboi M
Gen Thorac Cardiovasc Surg; 2024 Jan; 72(1):24-30. PubMed ID: 37268869
[TBL] [Abstract][Full Text] [Related]
15. An individualized nomogram for predicting and validating spread through air space (STAS) in surgically resected lung adenocarcinoma: a single center retrospective analysis.
Wang J; Yao Y; Tang D; Gao W
J Cardiothorac Surg; 2023 Nov; 18(1):337. PubMed ID: 37990253
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of the Proposed Pathologic Criteria for Invasion by the International Association for the Study of Lung Cancer in Resected Nonmucinous Lung Adenocarcinoma.
Hong TH; Hwang S; Cho J; Choi YL; Han J; Lee G; Jeon YJ; Lee J; Park SY; Cho JH; Choi YS; Kim J; Shim YM; Kim HK
J Thorac Oncol; 2024 Mar; 19(3):425-433. PubMed ID: 37924973
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of lymph node metastasis in resected adenosquamous lung cancer.
Kong M; Jin J; Cai X; Shen J; Ma D; Ye M; Zhu C; Freedman S; Walters K; Xu X; Chen B
Medicine (Baltimore); 2017 Dec; 96(48):e8870. PubMed ID: 29310370
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of preoperative carcinoembryonic antigen level in patients with clinical stage IA non-small cell lung cancer.
Maeda R; Suda T; Hachimaru A; Tochii D; Tochii S; Takagi Y
J Thorac Dis; 2017 Jan; 9(1):176-186. PubMed ID: 28203421
[TBL] [Abstract][Full Text] [Related]
19. [Construction of a Prognostic Prediction Model of Patients with Pathologic N0
in Resected Invasive Mucinous Adenocarcinoma of the Lung].
Wang Z; He J; Shen H; Chen X; Lin C; Yu H; Gao J; He X; Shen W
Zhongguo Fei Ai Za Zhi; 2024 Jan; 27(1):47-55. PubMed ID: 38296625
[TBL] [Abstract][Full Text] [Related]
20. Occult lymph node metastasis is not a favorable factor for resected NSCLC patients.
Cai JS; Yang F; Wang X
BMC Cancer; 2023 Sep; 23(1):822. PubMed ID: 37667180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
